Agilent Technologies, Inc. (A)
USD 108.63
(2.04%)
USD 108.63
(2.04%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.14 Billion USD | -33.28% |
| 2022 | 1.71 Billion USD | 37.83% |
| 2021 | 1.24 Billion USD | 35.62% |
| 2020 | 918 Million USD | -10.44% |
| 2019 | 1.02 Billion USD | 328.79% |
| 2018 | -448 Million USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | -100.0% |
| 2013 | 24 Million USD | 118.18% |
| 2012 | 11 Million USD | 0.0% |
| 2011 | - USD | -100.0% |
| 2010 | 1.04 Billion USD | 145.18% |
| 2009 | 425 Million USD | -40.97% |
| 2008 | 720 Million USD | 175.86% |
| 2007 | 261 Million USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 885 Million USD | 9.67% |
| 2024 Q3 | 1.15 Billion USD | 30.28% |
| 2024 Q1 | 807 Million USD | -29.52% |
| 2023 FY | 1.14 Billion USD | -33.28% |
| 2023 Q2 | 1.55 Billion USD | -9.47% |
| 2023 Q1 | 1.72 Billion USD | 0.29% |
| 2023 Q3 | 1.46 Billion USD | -6.29% |
| 2023 Q4 | 1.14 Billion USD | -21.58% |
| 2022 Q2 | 1.71 Billion USD | 6.31% |
| 2022 Q1 | 1.61 Billion USD | 29.88% |
| 2022 FY | 1.71 Billion USD | 37.83% |
| 2022 Q4 | 1.71 Billion USD | -6.79% |
| 2022 Q3 | 1.84 Billion USD | 7.1% |
| 2021 Q3 | 1.43 Billion USD | -7.86% |
| 2021 Q2 | 1.55 Billion USD | 32.65% |
| 2021 Q1 | 1.17 Billion USD | 27.45% |
| 2021 Q4 | 1.24 Billion USD | -12.94% |
| 2021 FY | 1.24 Billion USD | 35.62% |
| 2020 Q2 | 1.16 Billion USD | -5.83% |
| 2020 Q3 | 965 Million USD | -17.1% |
| 2020 Q4 | 918 Million USD | -4.87% |
| 2020 FY | 918 Million USD | -10.44% |
| 2020 Q1 | 1.23 Billion USD | 20.59% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q3 | 33 Million USD | 0.0% |
| 2019 Q4 | 1.02 Billion USD | 3006.06% |
| 2019 FY | 1.02 Billion USD | 328.79% |
| 2018 Q2 | - USD | 0.0% |
| 2018 FY | -448 Million USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | -667 Million USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 FY | -377 Million USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 FY | -348 Million USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q1 | - USD | -100.0% |
| 2014 FY | -266 Million USD | -100.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2013 Q3 | 371 Million USD | 0.0% |
| 2013 Q4 | 24 Million USD | -93.53% |
| 2013 FY | 24 Million USD | 118.18% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | -100.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q3 | 291 Million USD | 0.0% |
| 2012 Q4 | 11 Million USD | -96.22% |
| 2012 Q2 | - USD | 0.0% |
| 2012 FY | 11 Million USD | 0.0% |
| 2011 FY | -1.34 Billion USD | -100.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q1 | - USD | -100.0% |
| 2010 Q2 | 248 Million USD | -42.33% |
| 2010 Q1 | 430 Million USD | 1.18% |
| 2010 Q4 | 1.04 Billion USD | -23.44% |
| 2010 Q3 | 1.36 Billion USD | 448.79% |
| 2010 FY | 1.04 Billion USD | 145.18% |
| 2009 Q1 | 842 Million USD | 16.94% |
| 2009 Q4 | 425 Million USD | -36.94% |
| 2009 Q2 | 754 Million USD | -10.45% |
| 2009 Q3 | 674 Million USD | -10.61% |
| 2009 FY | 425 Million USD | -40.97% |
| 2008 Q2 | 664 Million USD | -10.39% |
| 2008 Q4 | 720 Million USD | 6.67% |
| 2008 FY | 720 Million USD | 175.86% |
| 2008 Q1 | 741 Million USD | 183.91% |
| 2008 Q3 | 675 Million USD | 1.66% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q4 | 261 Million USD | 1764.29% |
| 2007 Q1 | - USD | 0.0% |
| 2007 FY | 261 Million USD | 0.0% |
| 2007 Q3 | 14 Million USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 FY | -762 Million USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 FY | -2.22 Billion USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2004 FY | -1.16 Billion USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 FY | -457 Million USD | 0.0% |
| 2002 FY | -694 Million USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q2 | - USD | -100.0% |
| 2001 FY | -1.16 Billion USD | 0.0% |
| 2001 Q1 | 123 Million USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 FY | -886 Million USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Charles River Laboratories International, Inc. | 2.78 Billion USD | 58.955% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | 75.55% |
| Danaher Corporation | 13.67 Billion USD | 91.625% |
| Enzo Biochem, Inc. | -52.1 Million USD | 2297.444% |
| IQVIA Holdings Inc. | 12.85 Billion USD | 91.093% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | 78.864% |
| Mettler-Toledo International Inc. | 2.01 Billion USD | 43.064% |
| Qiagen N.V. | 943.04 Million USD | -21.416% |
| Revvity, Inc. | 3.11 Billion USD | 63.278% |
| Thermo Fisher Scientific Inc. | 26.84 Billion USD | 95.734% |
| Waters Corporation | 1.96 Billion USD | 41.595% |